Description
Mitrofan 50mg/500mg Tablets contain a combination of Sitagliptin and Metformin, used in the management of type 2 diabetes mellitus. This combination works by improving blood glucose control through complementary mechanisms, including enhancing insulin response and reducing glucose production.
Manufactured by Amros Pharmaceuticals under strict quality standards, Mitrofan ensures safety, consistency, and reliable therapeutic performance. The product is available in a fixed-dose combination tablet for convenient administration.
Dosage & Administration:
Dosage depends on patient condition and response to treatment. It is taken orally as prescribed by a qualified healthcare professional, usually with meals.
Possible Side Effects:
May include nausea, diarrhea, abdominal discomfort, or headache. In some cases, low blood sugar or gastrointestinal disturbances may occur. Serious side effects are rare but require medical attention.
Use only under the supervision of a licensed medical practitioner.
